NOTV.NASDAQInotiv, INC

Form 4: Inotiv CEO Sells Shares for Tax Obligations

Sentiment:

Insider Transaction Report


Inotiv, Inc. President and CEO, Robert Leasure Jr., sold 16,810 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

  • Robert Leasure Jr., President and CEO, and a Director of Inotiv, Inc. (NOTV), sold 16,810 shares of common stock.
  • The transaction occurred on February 17, 2026, at a weighted average price of $0.2953 per share, with individual sales prices ranging from $0.29 to $0.30 per share.
  • The sale was executed automatically by the company on behalf of Mr. Leasure Jr. to satisfy tax withholding obligations upon the vesting and settlement of restricted stock units.
  • This transaction was conducted under a Rule 10b5-1 instruction entered into by Mr. Leasure Jr. during the period from September 11, 2024, to October 9, 2024.
  • Following the sale, Mr. Leasure Jr. directly beneficially owns 1,256,215 shares and indirectly owns 105,000 shares through an entity for which he is the majority security holder.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale is for tax purposes and pre-planned, which is a routine part of executive compensation and not indicative of a change in management's outlook on the company.

Positives

  • The sale was pre-planned under a Rule 10b5-1 plan, indicating a structured approach to managing equity compensation and reducing concerns about opportunistic selling.

Negatives

  • A sale of shares by an insider, even for tax purposes, reduces their direct ownership stake in the company.

Future Outlook

This filing does not contain any forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that insider sales for tax withholding are a routine occurrence in publicly traded companies, especially for executives receiving equity compensation. This transaction is specific to Inotiv, Inc. and does not immediately reflect broader industry trends.

Comparison to Industry Standards

  • StockSavvy.ai observes that the use of Rule 10b5-1 plans for managing equity compensation and tax obligations is a standard practice among executives in publicly traded companies across various sectors, including biotechnology and contract research organizations (CROs) like Inotiv.
  • This practice is consistent with corporate governance best practices aimed at mitigating concerns about insider trading.

Stakeholder Impact

  • Shareholders: A minor reduction in direct insider ownership, but the overall beneficial ownership remains substantial.
  • Employees: No direct impact on employees mentioned.
  • Customers/Suppliers/Creditors: No direct impact mentioned.

Key Dates

DateDescription
09/11/2024Start of the period during which the Rule 10b5-1 instruction was entered into.
10/09/2024End of the period during which the Rule 10b5-1 instruction was entered into.
02/17/2026Date of the transaction where shares were sold.
02/19/2026Date the Form 4 was signed.

Recommendation

hold

This Form 4 filing details a routine, pre-planned sale of shares by the CEO to cover tax obligations related to restricted stock unit vesting. Such transactions are common and generally do not reflect a change in the insider's confidence in the company's future prospects. Given the nature of the transaction, it does not provide new fundamental information that would warrant a change in investment recommendation. Investors should continue to evaluate Inotiv based on its operational performance, financial results, and strategic initiatives.

Keywords

Inotiv, NOTV, Robert Leasure Jr., Insider Trading, Form 4, Stock Sale, Tax Withholding, Restricted Stock Units, 10b5-1 Plan, CEO

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.